InVivo Therapeutics Appoints Interim CEO, CFO to Replace Francis Reynolds

InVivo Therapeutics Holdings has appointed Michael J. Astrue as interim CEO and Sean Moran as acting CFO in the wake of former CEO and CFO Francis Reynolds resigning his posts due to a medical condition, according to a Hispanic Business report.

Advertisement

Mr. Moran currently serves as the company’s director of finance. Mr. Astrue is the non-executive chairman of the board at Vivus biopharmaceutical company. Both appointments are effective immediately.

InVivo’s board of directors will conduct a search for a permanent CEO throughout the year.

More Articles on Devices:
7 Spine-Focused Device Company Financial Reports
Zimmer PSI Shoulder System Receives FDA 510(k) Clearance
Hoag Memorial Hospital Adopts SECURE-C Cervical Disc Treatment

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.